 |
|
|
| |
48 Week Results of Once-Daily Maraviroc (MVC) 150 mg in Combination with Ritonavir-Boosted Atazanavir (ATV/r) Compared to Emtricitabine/Tenofovir (FTC/TDF) + ATV/r in Treatment-Na•ve Patients Infected with R5 HIV-1 (Study A4001078)
|
| |
| |
Reported by Jules Levin
6th IA Rome Italy July 17-20 2011
Anthony Mills presenter
|
| |
|
|
|
|
|
